-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Downgrades Biohaven to Sector Perform, Lowers Price Target to $19

Benzinga·09/08/2026 14:35:08
Listen to the news
RBC Capital analyst Leonid Timashev downgrades Biohaven (NYSE:BHVN) from Outperform to Sector Perform and lowers the price target from $23 to $19.